1. Home
  2. ALXO

as 05-21-2024 11:33am EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Founded: 2015 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 740.3M IPO Year: 2020
Target Price: $19.67 AVG Volume (30 days): 530.5K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.71 EPS Growth: N/A
52 Week Low/High: $3.94 - $17.83 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks:

Stock Insider Trading Activity of ALX Oncology Holdings Inc. (ALXO)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Randolph Sophia ALXO CHIEF MEDICAL OFFICER May 13 '24 Sell $15.82 10,203 $161,379.83 332,146 SEC Form 4
Randolph Sophia ALXO CHIEF MEDICAL OFFICER May 13 '24 Sell $16.67 1,797 $29,958.87 330,349 SEC Form 4
Pons Jaume ALXO PRESIDENT & CSO Apr 16 '24 Sell $14.20 50,000 $710,195.00 604,205 SEC Form 4
Pons Jaume ALXO PRESIDENT & CSO Apr 4 '24 Sell $11.15 20,000 $223,036.00 628,359 SEC Form 4
Lettmann Jason ALXO CHIEF EXECUTIVE OFFICER Mar 14 '24 Buy $11.31 4,400 $49,771.48 171,620 SEC Form 4
Pinto Shelly ALXO SVP, Finance and CAO Jan 4 '24 Sell $13.60 2,717 $36,956.63 78,591 SEC Form 4
Pons Jaume ALXO President & CSO Dec 29 '23 Sell $15.04 7,179 $107,972.16 618,359 SEC Form 4
Pinto Shelly ALXO SVP, Finance and CAO Dec 29 '23 Sell $15.04 1,631 $24,530.24 81,308 SEC Form 4
GARCIA PETER S ALXO Chief Financial Officer Dec 29 '23 Sell $15.04 1,893 $28,470.72 85,348 SEC Form 4
Randolph Sophia ALXO Chief Medical Officer Dec 29 '23 Sell $15.04 3,128 $47,045.12 312,349 SEC Form 4